Sign in

CIK 0001684144 · Non-accelerated filer<br>Smaller reporting company

Zomedica Corp.

Sign in to watch
Ticker
ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Alberta, Canada
Entity type
operating
Phone
(734) 369-2555
Business address
1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
Former names
Zomedica Pharmaceuticals Corp.
  1. 4 Open-market buy Sr Vice President, Sales bought 253,007 shares at $0.08 ($20,241)
  2. 4 Open-market buy Sr Vice President, Sales bought 1,056,064 shares at $0.04 ($42,243)
  3. 4 Open-market buy Sr Vice President of Sales bought 500,000 shares at an average $0.04 ($19,500)
  4. 4 Open-market buy Sr Vice President of Sales bought 500,000 shares at $0.04 ($20,000)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy COO bought 100,000 shares at an average $0.05 ($4,964)
  10. 4 Open-market buy General Counsel/Corporate Secy bought 104,300 shares at $0.05 ($5,006)
  11. 4 Open-market buy Director bought 500,000 shares at $0.05 ($23,000)
  12. 4/A Open-market buy Director bought 1,439,005 shares at an average $0.07 ($96,098)
  13. 4 Open-market buy Director bought 100,000 shares at $0.07 ($6,900)
  14. 4 Open-market buy Chief Financial Officer bought 300,000 shares at $0.06 ($18,600)
  15. 4 Open-market buy Director bought 1,439,005 shares at an average $0.07 ($96,098)
  16. 4 Open-market buy Director bought 143,000 shares at $0.06 ($8,437)
  17. 4 Open-market buy Director bought 500,000 shares at an average $0.07 ($33,650)
  18. 4 Open-market buy CEO bought 500,000 shares at an average $0.06 ($29,702)
  19. 4 Open-market buy COO bought 500,000 shares at $0.06 ($30,000)
  20. 4 Open-market buy Sr Vice President of Sales bought 699,980 shares at $0.07 ($48,999)

Page 2 of 10 · 183 filings